CSI Market
Sign In | Register

Altamira Therapeutics Ltd (CYTO) Annual Balance Sheets

Annual · GAAP · USD millions
Access CYTO quarterly Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Altamira Therapeutics Ltd balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Assets
Cash And Cash Equivalents1.00
Cash & Short-term Investments0.00
Trade & Other Current Receivables (IFRS combined total)-
Inventories0.10
Other Current Assets0.00
Total Current Assets1.54
Equipment/Property/Plant Net0.10
Intangible Assets4.63
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Trade And Other Current Receivables-
Other Current Receivables0.07
Current Prepayments0.28
Intangible Assets Other Than Goodwill3.89
Other Noncurrent Receivables0.08
Investments In Subsidiaries Joint Ventures And Associates2.42
Noncurrent Assets6.47
Total Assets8.65
Liabilities
Accounts Payable0.55
Current Portion Of Longterm Borrowings0.00
Other Liabilities, Current0.00
Total Current Liabilities1.16
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI0.00
Other liabilities, Noncurrent0.00
Noncurrent Derivative Financial Liabilities-
Noncurrent Provisions For Employee Benefits0.35
Deferred Tax Liability Asset-
Noncurrent Liabilities0.35
Trade And Other Current Payables0.44
Accruals Classified As Current0.35
Total Liabilities2.09
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity6.57
Total Stockholder's Equity6.57
Liabilities & Stockholder's Equity8.65
4 historic quarters locked

Sign in to unlock the full Altamira Therapeutics Ltd balance sheet history.

Sign In Create Free Account

About Altamira Therapeutics Ltd Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-25-037199

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License